[1]李 铎.β受体阻滞剂预处理对AMI介入治疗患者心室重构、 自主神经功能恢复的影响研究[J].医学信息,2018,31(09):91-93.[doi:10.3969/j.issn.1006-1959.2018.09.027]
　LI Duo.Effect of β-blocker Preconditioning on Ventricular Remodeling and Autonomic Nerve Function Recovery in Patients Undergoing AMI Intervention[J].Journal of Medical Information,2018,31(09):91-93.[doi:10.3969/j.issn.1006-1959.2018.09.027]
点击复制

β受体阻滞剂预处理对AMI介入治疗患者心室重构、 自主神经功能恢复的影响研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年09期
页码:
91-93
栏目:
论著
出版日期:
2018-05-01

文章信息/Info

Title:
Effect of β-blocker Preconditioning on Ventricular Remodeling and Autonomic Nerve Function Recovery in Patients Undergoing AMI Intervention
文章编号:
1006-1959（2018）09-0091-03
作者:
李 铎
佳木斯市中心医院心内科，黑龙江 佳木斯 154002
Author(s):
LI Duo
Department of Cardiology,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China
关键词:
β受体阻滞剂; AMI; 介入治疗; 心室重构; 自主神经功能
Keywords:
Key words：β-blockers; AMI; Interventional therapy; Ventricular remodeling; Autonomic nervous system function
分类号:
R542.22
DOI:
10.3969/j.issn.1006-1959.2018.09.027
文献标志码:
A
摘要:
目的 研究β受体阻滞剂预处理对急性心肌梗塞（AMI）介入治疗患者心室重构、自主神经功能恢复的影响。方法 收集我院自2015年9月~2017年9月收治的接受介入手术治疗的AMI患者90例作为观察对象，按随机数字表法分为观察组与对照组，每组45例。对照组早期给予常规药物干预，观察组则在对照组的基础上增加β受体阻滞剂行预处理。评估并对比两组心室重构、自主神经功能改善及预后情况。结果 治疗后，两组ESVI、血清MMP-2指标均低于入院时（P＜0.05），且观察组低于同时期对照组（P＜0.05）；两组EDVI、LVEF均高于入院时（P＜0.05），且观察组高于同时期对照组（P＜0.05）。治疗后，两组SDNN、SDANN指标均升高，且观察组高于同时期对照组（P＜0.05），接近正常水平；而两组治疗后LF/HF均低于入院时（P＜0.05），且观察组低于同时期的对照组（P＜0.05）。随访半年，两组心血管事件发生率比较，差异无统计学意义（P＞0.05）。结论 β受体阻滞剂预处理能够改善AMI介入治疗患者心室重构及自主神经功能，改善预后，具有较高的推广价值。
Abstract:
Abstract：Objective To study the effects of β-blocker preconditioning on ventricular remodeling and autonomic nerve function recovery in patients with acute myocardial infarction(AMI).Methods We collected 90 cases of AMI patients undergoing interventional surgery in our hospital from September 2015 to September 2017 as observation objects,and were divided into observation group and control group according to the random number table method,45 cases in each group.The control group received conventional drug intervention at an early stage,while the observation group increased β-blocker pretreatment on the basis of the control group.The ventricular remodeling,improvement of autonomic function and prognosis of the two groups were assessed and compared.Results After treatment,the serum levels of ESVI and MMP-2 in both groups were lower than those at admission(P<0.05),and the observation group was lower than the control group at the same time(P<0.05).Both EDVI and LVEF were higher than those at the time of admission(P<0.05),and the observation group was higher than the control group at the same time(P<0.05).After treatment,both SDNN and SDANN indicators increased,and the observation group was higher than the control group at the same time(P<0.05),and was close to the normal level; and the LF/HF of the two groups was lower than that of the admission(P<0.05).The observation group was lower than the control group in the same period(P<0.05).After six months of follow-up,there was no statistically significant difference in the incidence of cardiovascular events between the two groups(P>0.05).Conclusion β-blocker preconditioning can improve the ventricular remodeling and autonomic function of patients undergoing AMI intervention and improve their prognosis.It has a higher value of promotion.

参考文献/References:

[1]吴志刚,谢彬,杨国康,等.β受体阻滞剂治疗时机不同对冠脉介入患者远期预后的影响[J].实用药物与临床,2015,18(3):304-307.
[2]郑霄,胡晓晟.美托洛尔联合贝那普利治疗对老年高血压合并心力衰竭患者治疗的心脏结构及心功能的影响[J].中国生化药物杂志,2017,37(1):160-162.
[3]王妮,刘伟,毕四锐,等.美托洛尔对心力衰竭患者的 TNF-α、IL-1β、IL-6及心功能NYHA分级状况的影响及机制研究[J].中国临床医生杂志,2016,44(7):31-34.
[4]中华医学会心血管病分会,中华心血管病杂志编辑委员会,中国循环杂志编辑委员会.急性心肌梗死诊断和治疗指南[J].中华心血管病杂志,2001,29(12):710-725.
[5]田辉,李龙,邓维杰,等.美托洛尔联合螺内酯治疗慢性心功能不全的疗效及对心功能与血浆NT-proBNP水平的影响[J].中西医结合心脑血管病杂志,2017,15(13):1605-1608.
[6]陈慧娟,徐陵琦,李纪明,等.β受体阻滞剂治疗时机对冠状动脉介入患者远期预后的影响[J].中国循证心血管医学杂志,2015,7(4):451-453.
[7]高波,许红阳.胺碘酮联合β受体阻滞剂治疗急性心肌梗死并发快速心律失常的疗效观察[J].中西医结合心脑血管病杂志,2016,14(8):882-884.

相似文献/References:

[1]邵俊丽.静息心率与脑卒中关系的研究[J].医学信息,2018,31(16):16.[doi:10.3969/j.issn.1006-1959.2018.16.006]
　SHAO Jun-li.Research on Relationship between Resting Heart Rate and Stroke[J].Journal of Medical Information,2018,31(09):16.[doi:10.3969/j.issn.1006-1959.2018.16.006]
[2]赖子梅,王 珊.β受体阻滞剂治疗婴幼儿血管瘤的研究进展[J].医学信息,2019,32(09):54.[doi:10.3969/j.issn.1006-1959.2019.09.018]
　LAI Zi-mei,WANG Shan.Progress in the Study of β-blockers in the Treatment of Infantile Hemangiomas[J].Journal of Medical Information,2019,32(09):54.[doi:10.3969/j.issn.1006-1959.2019.09.018]

更新日期/Last Update: 2018-05-01